Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
 
  
   
Insider Information:   Dobmeier Eric
Relationship:   President, CEO, Director
City:   Bothell
State:   WA
   
Insider Summary:
  
   
Companies Owned :   6    
Direct Shares   730,812    

Indirect Shares

   0      
Direct Value   $28,069,465    

Indirect Value

   $0      
Total Shares   730,812      
Total Value   $28,069,465      


Seagen Inc $27,416,776 Stemline Therapeutics Inc $330,802 Atara Biotherapeutics, Inc. $315,969 Aravive Inc $728 Adaptive Biotechnologies Corp $5,189 Seagen Inc $27,416,776 Stemline Therapeutics Inc $330,802 Atara Biotherapeutics, Inc. $315,969 Aravive Inc $728 Adaptive Biotechnologies Corp $5,189
 


Historical Performance :
Based on 6 Month Return Percentages
Buys 
Sells 

     Total Filings :
    13   
    3    

     Stock price went up :
    7   
    3    
     Stock price went down :
    6   
    0    
   
     Gain/Loss Ratio :
   1.2   
   3.0   
     Percentage Gain/Loss :
   17.0%
 198.2%
     
   
Holdings :
     Menu Company Name Ticker Relation Direct Date Direct Shares Indirect Date Indirect Shares Total Value Sold  
            Seagen Inc SGEN Chief Operating Officer 2017-12-04 119,860 2004-05-05 0    Premium*  
            Stemline Therapeutics Inc STML Director 2017-06-19 27,963 0    Premium*  
            Atara Biotherapeutics, Inc. ATRA 2023-11-10 563,325 2015-12-16 0    Premium*  
            Aravive Inc ARAV Director 2017-12-20 18,160 2017-05-25 0    Premium*  
            Adaptive Biotechnologies Corp ADPT Director 2021-02-14 1,504 2019-12-26 0    Premium*  
            Chinook Therapeutics Inc KDNY President, CEO, Director 2023-08-11 0 2020-10-05 0    Premium*  
* Premium Members only  

Records found :    177         Free Registration Required For Full Results.    Limit: 25

 Download
  Page 5 of 8
Ticker Company Name Relation   Off-Dir-10% Trans. Date Form Action Price Mkt Value D/I Shares    Holdings   
Rank

  
3m +/-  
Form
SGEN Seagen Inc Chief Business Officer   •       –      –    2009-07-29 4 S $12.36 $324,755 D/D (26,266) 12,206 0 -
SGEN Seagen Inc Chief Business Officer   •       –      –    2009-07-30 4 S $12.36 $417,050 D/D (33,734) 12,206 0 -
KDNY Chinook Therapeutics Inc President, CEO   •       •      –    2022-05-25 4 B $13.03 $65,148 D/D 5,000 205,880 2.81 %
KDNY Chinook Therapeutics Inc President, CEO   •       •      –    2020-12-09 4 B $13.08 $26,150 D/D 2,000 56,837 2.81 %
KDNY Chinook Therapeutics Inc President, CEO   •       •      –    2020-12-08 4 B $13.24 $26,483 D/D 2,000 54,837 2.81 %
KDNY Chinook Therapeutics Inc President, CEO   •       •      –    2020-11-19 4 B $13.50 $6,750 D/D 500 51,337 2.81 %
KDNY Chinook Therapeutics Inc President, CEO   •       •      –    2020-11-23 4 B $13.67 $12,699 D/D 929 52,837 2.81 %
KDNY Chinook Therapeutics Inc President, CEO   •       •      –    2020-11-20 4 B $13.69 $7,817 D/D 571 51,908 2.81 %
KDNY Chinook Therapeutics Inc President, CEO   •       •      –    2020-11-11 4 B $13.75 $34,375 D/D 2,500 50,837 2.81 %
ATRA Atara Biotherapeutics, In... Director   –       •      –    2016-03-17 4 B $13.86 $41,565 D/D 3,000 5,500 2.39 -
KDNY Chinook Therapeutics Inc President, CEO   •       •      –    2020-11-10 4 B $13.86 $27,720 D/D 2,000 48,337 2.81 %
KDNY Chinook Therapeutics Inc President, CEO   •       •      –    2021-05-14 4 B $14.44 $14,440 D/D 1,000 77,837 2.81 %
SGEN Seagen Inc Chief Operating Officer   •       –      –    2013-09-05 4 OE $15.46 $231,900 D/D 15,000 150,843 0 -
SGEN Seagen Inc Chief Operating Officer   •       –      –    2013-09-10 4 OE $15.46 $889,599 D/D 40,000 151,672 0 -
SGEN Seagen Inc Chief Operating Officer   •       –      –    2015-08-24 4 OE $15.46 $99,985 D/D 4,933 79,340 0 -
SGEN Seagen Inc Chief Operating Officer   •       –      –    2017-08-31 4 OE $15.46 $386,500 D/D 25,000 142,424 0 -
SGEN Seagen Inc Chief Operating Officer   •       –      –    2017-11-15 4 OE $15.46 $148,416 D/D 9,600 127,024 0 -
SGEN Seagen Inc Chief Operating Officer   •       –      –    2017-11-16 4 OE $15.46 $311,617 D/D 15,400 125,913 0 -
SGEN Seagen Inc Chief Business Officer   •       –      –    2011-04-05 4 AS $16.00 $640,000 D/D (40,000) 25,802 0 -
SGEN Seagen Inc Chief Business Officer   •       –      –    2011-05-13 4 AS $18.00 $768,870 D/D (42,715) 25,802 0 -
SGEN Seagen Inc Chief Operating Officer   •       –      –    2012-02-28 4 S $18.52 $851,938 D/D (46,000) 72,073 0 -
ATRA Atara Biotherapeutics, In... Director   –       •      –    2019-06-27 4 B $19.50 $39,000 D/D 2,000 16,000 2.39 -
SGEN Seagen Inc Chief Operating Officer   •       –      –    2012-04-25 4 AS $19.95 $498,750 D/D (25,000) 68,073 0 -
SGEN Seagen Inc Chief Business Officer   •       –      –    2011-06-09 4 AS $20.00 $72,000 D/D (3,600) 22,202 0 -
SGEN Seagen Inc Chief Operating Officer   •       –      –    2011-06-20 4 AS $20.00 $267,700 D/D (13,385) 8,817 0 -
  177  Records found
  1   2   3   4   5  6   7   8      
  Page 5 of 8  
 
Free Registration Required For Full Results.    Limit: 25

 
 
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
OE - Options Exercised A - Aquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us